FMC Sells 20% Stake to Belgian Firm Tessenderlo in $400 Million Deal
FMC Corporation has sold a 20% stake to Belgian company Tessenderlo Group for $400 million, addressing its financial challenges after a significant loss in 2025. This deal, valued at $13.30 per share, marks FMC's largest recent move to reduce debt, following a bond offering and asset sales. Tessenderlo's CEO, Luc Tack, described the investment as a strategic minority position focused on FMC's promising portfolio of agricultural innovations, allowing FMC to maintain its independence for the foreseeable future.
The Authority Supreme from FMC Corp. - herbicide workhorse in corn and soybean fields
The Authority Supreme herbicide from FMC Corp. is highlighted as a dual-mode-of-action preemergent residual herbicide crucial for managing resistant weeds in corn and soybean fields. It combines sulfentrazone and pyroxasulfone, offering broad-spectrum control, particularly against tough broadleaf and grass weeds like waterhemp and Palmer amaranth. The article details its technical performance, regulatory status, and market role, emphasizing its significance for FMC Corp.'s crop protection segment and overall farmer profitability despite being a notable operating cost.
BMO Capital Maintains FMC Corp(FMC.US) With Hold Rating, Cuts Target Price to $14
BMO Capital has reiterated its Hold rating on FMC Corp (FMC.US) stock while reducing its target price to $14. This adjustment reflects a continued cautious outlook from the firm regarding FMC Corp's financial prospects or market position.
FMC - FMC Corp Options
This article provides a detailed financial overview of FMC Corp (FMC), including its last close price, various financial ratios, performance metrics, and insider/institutional ownership data. It lists key financial figures such as market cap, income, sales, dividends, and earnings per share. The report also covers trading statistics like volatility, short interest, and price performance over different periods.
FMC Corp. stock outperforms competitors on strong trading day
FMC Corp. (FMC) stock rose 3.65% to $11.35 on Thursday, outperforming the mixed trading session for the broader market. This gain broke a three-day losing streak for the company's shares. The S&P 500 remained largely unchanged, while the Dow Jones Industrial Average saw a 1.14% increase.
FMC Shares Rise Premarket on Investment From Tessenderlo Group
Shares of FMC Corporation are rising in premarket trading following an announcement from Tessenderlo Group. The Belgium-based chemical company disclosed it has acquired a 3.4% stake in FMC, representing approximately 4.25 million shares. This strategic investment positions Tessenderlo as FMC's third-largest shareholder.
FMC Corp. stock underperforms Wednesday when compared to competitors
Shares of FMC Corp. (FMC) fell 4.78% on Wednesday, closing at $10.95. This underperformance occurred on a generally grim trading day where the S&P 500 Index (SPX) declined 0.22% and the Dow Jones Industrial Average (DJIA) fell 0.03%. This marks the third consecutive day of losses for FMC Corp. stock.
FMC sells 20% ownership stake, capping flurry of deals to pay off $1B of debt
FMC Corp. has sold a 20% ownership stake to Tessenderlo Group for $400 million, concluding a series of deals since February. These transactions aim to help FMC recover from a significant $2 billion loss in 2025 and pay down $1 billion in debt. The company had previously announced sales of its campus and a unit as part of this deleveraging strategy.
FMC Raises $403.2 Million in Private Stock Sale to Tessenderlo at $13.30, Targeting 20% Stake
FMC has announced a private placement deal with Tessenderlo Group, selling over 30 million common shares for $403.2 million at $13.30 per share. This transaction aims to give Tessenderlo a 20% ownership stake in FMC and is contingent on customary approvals. The agreement includes an Investor Agreement granting Tessenderlo a board nominee, a 36-month lock-up, and preemptive rights, along with a Registration Rights Agreement.
FMC lands $400M from Tessenderlo in deal for 20% stake
FMC Corporation has announced a definitive agreement for a $400 million strategic minority equity investment from Tessenderlo Group, giving Tessenderlo approximately 20% ownership at $13.30 per share. FMC intends to use the proceeds to pay down debt, aiming for a $1 billion reduction target. This investment concludes FMC's strategic options review and is part of broader actions to improve financial flexibility, including a $1.2 billion secured high-yield bond, sale of its India commercial business, and a prepayment from Corteva.
FMC Corp. stock underperforms Monday when compared to competitors
FMC Corp. (FMC) stock dropped 1.79% on Monday, closing at $11.54, despite a generally positive day for the stock market, with the S&P 500 Index rising 1.18% and the Dow Jones Industrial Average up 0.59%. This performance leaves FMC Corp. 74.17% below its 52-week high of $44.68.
FMC Corp To Go Ex-Dividend On June 30th, 2026 With 0.08 USD Dividend Per Share
FMC Corp (NYSE:FMC) has announced it will go ex-dividend on June 30th, 2026. Shareholders can expect a dividend of 0.08 USD per share. This information is crucial for investors tracking dividend payouts.
FMC Corp. sells Delaware site for $114 million, shares steady on NYSE
FMC Corp. has agreed to sell a Delaware property for $114 million, a move aimed at focusing on its core crop protection business. The specialty chemicals group's shares continue to trade steadily on the NYSE. This sale is part of the company's strategy to streamline operations and reallocate capital towards its primary agrochemical portfolio, aligning with similar actions by peers like Corteva and Bayer Crop Science.
FMC Corp. stock outperforms competitors on strong trading day
FMC Corp. (FMC) stock rose by 3.80% to $11.75 on Friday, outperforming the S&P 500 Index and Dow Jones Industrial Average, which experienced slight declines. Despite the daily gain, the company's shares closed 73.70% below its 52-week high of $44.68. The article highlights FMC Corp.'s strong performance on a generally negative trading day for the broader market.
FMC Corp Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh Actuals & Estimates (BMFBOVESPA:F1MC34)
This article provides an overview of FMC Corp Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh (F1MC34) on TradingView, focusing on its financial actuals and estimates. It allows users to explore reported financial data and analyst estimates across income statements, balance sheets, cash flow statements, and valuation metrics. The platform enables comparison of actual results with average, high, and low estimates, and offers visualization of trends over time for both annual and quarterly data.
FMC Corp. to sell R&D campus for $114 million to pay down debt
FMC Corporation is selling its 255-acre Stine Research Center in Newark, Delaware, to Broadstone for $114 million. This move is part of the company's strategy to pay down debt after experiencing a significant loss of over $2 billion in 2025. The sale follows previous efforts by FMC to divest assets and potentially explore a full company sale.
FMC Arranges $114M Sale-Leaseback For Delaware Research Campus: The Philadelphia Deal Sheet
FMC Corporation has arranged a $114 million sale-leaseback agreement for its Stine Research Center in Newark, Delaware, with Ercor Elkton as the buyer; the deal is expected to close in Q4 2026. This move allows FMC to optimize its physical footprint while retaining its global headquarters at the campus. The article also provides updates on other real estate deals, construction projects, and personnel changes in the Philadelphia area.
FMC Corp. stock outperforms competitors on strong trading day
FMC Corp. (FMC) shares gained 2.72% to $11.32 on Wednesday, outperforming the broader market. This rise broke a three-day losing streak for the company's stock, despite a mixed trading session where the Dow Jones Industrial Average rose and the S&P 500 Index declined.
FMC to Sell Newark Property for $114M, Use Proceeds to Cut Debt
FMC Corporation has announced a framework agreement to sell its Newark, DE property for approximately $114 million. The company plans to lease back its current facilities and will use the proceeds to reduce debt as part of an effort to optimize its asset base. The transaction is expected to close in Q4 2026, though leaseback terms are still under preliminary negotiations.
FMC (NYSE: FMC) plans $114M Delaware campus sale to cut debt
FMC Corporation announced it has entered into a framework agreement to sell underutilized buildings and land at its Stine Research Center campus in Newark, Delaware, to Ercor Elkton, LLC for approximately $114 million. The company plans to negotiate a leaseback arrangement to continue core research operations at the site, with the proceeds from the sale intended for debt reduction. The transaction is expected to close in the fourth quarter, though it remains preliminary and subject to due diligence and other conditions.
FMC (NYSE: FMC) alters credit agreement liens and releases some collateral
FMC Corporation has amended its Fifth Amended and Restated Credit Agreement, effective June 16, 2026. This amendment, known as Amendment No. 7, modifies the limitation on liens within the credit facility and releases security interests on certain collateral previously securing the company's obligations. Citibank, N.A. continues as the administrative agent for the syndicate of lenders involved in the agreement.
FMC to Sell Delaware Property for About $114 Million to Ercor Elkton, Plans Leaseback
FMC has entered into an agreement to sell underutilized buildings and land at its Stine Research Center campus in Newark, Delaware, to Ercor Elkton for approximately $114 million. The company plans to negotiate a leaseback to continue operations without impacting research capabilities, with the closing targeted for the fourth quarter. FMC intends to use the proceeds to pay down debt, while retaining ownership of its adjacent Maryland property.
FMC Corporation announces date for second quarter 2026 earnings release and webcast conference call
FMC Corporation (NYSE: FMC) has announced it will release its second quarter 2026 earnings on Wednesday, July 29, 2026, after the stock market closes. The company will also host a webcast conference call on Thursday, July 30, 2026, at 9:00 a.m. ET to discuss the results, which will be accessible via internet broadcast and telephone.
Favourable Signals For FMC: Numerous Insiders Acquired Stock
The article highlights recent insider buying activity at FMC Corporation, indicating a positive sentiment towards the company from its leadership. Several key insiders, including the Chairman and multiple Executive Vice Presidents, purchased shares, suggesting their confidence in the company's future performance. This strong insider buying trend often signals potential undervaluation or expected good news for the stock.
FMC Corporation announces date for second quarter 2026 earnings release and webcast conference call
FMC Corporation (NYSE: FMC) has announced it will release its second quarter 2026 earnings on Wednesday, July 29, 2026, after the stock market closes. The company will also host a webcast conference call on Thursday, July 30, 2026, at 9:00 a.m. ET, accessible via its investor relations website and telephone. This call is open to the public and will cover the financial results for the quarter.
FMC Corporation Announces $114 Million Sale-Leaseback of Newark, Delaware Property
FMC Corporation announced a framework agreement to sell its Newark, Delaware property for approximately $114 million, with plans to lease back the facilities for its global R&D headquarters. The transaction aims to optimize asset utilization, reduce debt, and will not disrupt the Stine Research Center's operations. The sale is expected to close in the fourth quarter of 2026, subject to due diligence and various closing conditions.
FMC Corporation Announces $114 Million Sale-Leaseback of Newark, Delaware Property
FMC Corporation announced a framework agreement to sell its Newark, Delaware property for approximately $114 million USD, with plans to lease back the facilities. This strategic move aims to optimize asset utilization, reduce debt, and sustain the company's global R&D headquarters at the Stine Research Center. The transaction is expected to close in Q4 2026, contingent on due diligence and other closing conditions.
FMC Corporation announces date for second quarter 2026 earnings release and webcast conference call
FMC Corporation (NYSE: FMC) has announced it will release its second quarter 2026 earnings on Wednesday, July 29, 2026, after the stock market closes. The company will also host a webcast conference call on Thursday, July 30, 2026, at 9:00 a.m. ET, available to the public via internet broadcast and telephone. Details for accessing the webcast and conference call, including dial-in numbers and a pre-registration link, have been provided.
FMC schedules July 29 earnings release, July 30 webcast call
FMC Corporation (NYSE: FMC) announced it will release its second quarter 2026 earnings on Wednesday, July 29, 2026, after market close. The company will also host a public webcast conference call on Thursday, July 30, 2026, at 9:00 a.m. ET to discuss the results. The announcement includes details for investors to access the earnings information and webcast.
FMC Corp. stock underperforms Monday when compared to competitors
FMC Corp. (FMC) shares fell 4.50% on Monday, closing at $11.03, even as the Dow Jones Industrial Average rose. The stock's underperformance marked its second consecutive day of losses. This occurred during a mixed trading session where the S&P 500 Index declined.
Citi Maintains FMC Corp(FMC.US) With Hold Rating, Cuts Target Price to $14
Citi has reiterated its Hold rating for FMC Corp (FMC.US) but has reduced the target price to $14. This adjustment reflects the bank's updated outlook on the company's financial performance and market conditions. Investors will be watching how this revised target price impacts FMC's stock movement.
FMC Corp. Sale Decision Could Come This Summer for Philadelphia Pesticide Giant
FMC Corp., a Philadelphia-based pesticide giant, awaits a potential sale decision as early as July, following a strategic review triggered by a business downturn. While acquisition talks are ongoing and the pool of buyers is shrinking, the company is slashing costs, paying down debt, and leveraging a new licensing deal with Corteva for its rimisoxafen herbicide technology. The outcome will significantly impact its workforce, shareholders, and the broader Philadelphia business community as it navigates a potential transition from a turnaround to a takeover story.
BofA Securities Maintains FMC Corp(FMC.US) With Hold Rating, Announces Target Price $19
BofA Securities has maintained its Hold rating on FMC Corp (FMC.US) and set a target price of $19.
FMC Financials: Revenue Breakdown, Margins & Competitor Comparison
This article provides a financial analysis of FMC Corp (FMC), detailing its revenue breakdown, profitability margins, and a comparison with competitors ODC and UAN. FMC's largest revenue contributor is Herbicides, accounting for 40.6% of total sales, with an overall gross margin of 32.51%. The analysis highlights the importance of understanding these financial metrics for investors in the Agricultural Chemicals industry.
FMC Corp. stock underperforms Thursday when compared to competitors
FMC Corp. (FMC) shares fell 3.59% on Thursday, closing at $11.55, despite a positive trading session for the broader market. The S&P 500 Index and Dow Jones Industrial Average both saw gains, making FMC Corp.'s performance an underperformance compared to its competitors and the market. This decline ended a two-day winning streak for the stock.
FMC boss says the company could be sold by July
FMC CEO Pierre Brondeau announced that the pesticide company could be sold by the end of July. Despite preliminary talks with potential acquirers, Brondeau aims to keep FMC independent by cutting costs and boosting sales through new chemical approvals. However, the company's share value previously plunged, leading to dividend cuts and efforts to raise $1 billion from asset sales and licensing deals to reduce debt.
FMC Up Nearly 9%, on Pace for Largest Percent Increase Since April 2025 -- Data Talk
This article reports that FMC Corporation's stock is up by nearly 9%, putting it on track for its largest percentage increase since April 2025. This significant rise highlights a positive movement in the company's stock performance.
FMC Corp (FMC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a detailed revenue breakdown for FMC Corp (FMC), categorized by business segment and geographical region. It highlights that insecticides represent the largest business segment, accounting for 45.36% of revenue, while Latin America is the leading regional contributor at 38.97%. The data is current as of April 6, and shows real-time stock quotes and market capitalization for FMC.
FMC Corp. and Corteva Expand Access to Breakthrough Rimisoxafen Herbicide Technology
FMC Corporation and Corteva, Inc. have announced a co-exclusive strategic supply and license agreement to expand access to FMC's rimisoxafen herbicide technology in North and South America's corn and soybean markets. This collaboration aims to provide growers with a new tool to combat herbicide-resistant weeds, including Amaranthus species, utilizing rimisoxafen's breakthrough dual mode of action. The agreement ensures broad availability of this innovative technology, with first commercial sales anticipated by the end of the decade pending regulatory approvals.
FMC, Corteva to partner on herbicide technology supply and license deal (FMC:NYSE)
FMC Corporation has announced a co-exclusive strategic supply and license agreement with Corteva, leading to a 2.2% post-market stock increase for FMC. This partnership aims to expand the availability of FMC's rimisoxafen technology in the North and South American corn and soybean markets. The terms of the deal extend through 2038.
New herbicide pact targets resistant weeds costing farmers billions
FMC Corporation and Corteva, Inc. have signed a co-exclusive strategic supply and license agreement for FMC's rimisoxafen herbicide technology, expanding its access across North and South American corn and soybean markets. This collaboration aims to provide a critical tool against herbicide-resistant weeds, including Amaranthus species, which cause billions in annual crop losses. Corteva will make an initial prepurchase payment of $200 million to FMC, with first commercial sales anticipated by the end of the decade, pending regulatory approvals.
FMC (FMC) CEO Brondeau reports tax-withholding of 34,177 vested shares
FMC Corporation's Chairman, CEO, and President, Pierre R. Brondeau, reported a tax-related disposition of 34,177 shares of Common Stock on June 11, 2026, at a price of $10.80 per share. This transaction was to cover tax liabilities on 74,314 shares that vested on the same day, which were originally granted on June 11, 2024. Following this withholding, Brondeau directly holds 533,869 FMC shares, as detailed in a Form 4 SEC filing.
FMC Corp. stock underperforms Monday when compared to competitors
FMC Corp. (FMC) shares fell 2.87% on Monday, closing at $11.51, despite an overall positive trading day for the stock market. The S&P 500 Index rose 1.65% and the Dow Jones Industrial Average increased by 0.92%. This decline ended a two-day winning streak for FMC Corp. stock.
FMC Corp. Stock (US3024913036): Valuation Comes Into Focus After Prolonged Downturn
FMC Corp.'s stock has seen a significant downturn over the past year, pushing its valuation metrics to multi-year lows due to investor concerns about growth and earnings in the crop protection market. This prolonged decline reflects demand normalization, inventory adjustments, and pricing pressures, leading to a more cautious market assessment of its future profitability and growth outlook. The current valuation suggests that investors are considering higher perceived risks around future earnings visibility compared to competitors and broader market benchmarks.
RBC Capital Maintains FMC Corp(FMC.US) With Hold Rating, Cuts Target Price to $14
RBC Capital has maintained its "Hold" rating for FMC Corp (FMC.US) but has reduced the target price from $17 to $14. Analyst Arun Viswanathan, according to TipRanks data, has a 51.6% success rate and an average return of 1.9% over the past year. This report is for informational purposes only and does not constitute investment advice.
FMC Corp. stock outperforms competitors on strong trading day
FMC Corp. (FMC) stock rose 5.15% to $11.85 on Friday, outperforming the broader market as the S&P 500 Index and Dow Jones Industrial Average also saw gains. This marks the second consecutive day of increases for the company's shares.
FMC Corp. stock outperforms competitors on strong trading day
FMC Corp. (FMC) stock rose 4.35% to $11.27 on Thursday, outperforming the broader market during a strong trading session where the S&P 500 and Dow Jones Industrial Average also saw significant gains. Despite this performance, FMC Corp. closed 74.78% below its 52-week high.
FMC stock hits 52-week low at 10.91 USD
FMC Corporation's stock has reached a 52-week low of $10.91, currently trading at $10.89 with a market cap of $1.37 billion and a significant debt burden of $4.66 billion. Despite a 75.12% decrease in value over the last year, InvestingPro analysis suggests the stock is undervalued, with analysts predicting profitability for the current year. This decline comes after FMC reported better-than-expected first-quarter 2026 earnings, leading to reiterated Buy ratings from Goldman Sachs and increased price targets from RBC Capital.
FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at Wolfe Research 3rd Annual Materials of the Future Conference
FMC Corporation announced that its CEO, Pierre Brondeau, and CFO, Andrew Sandifer, will speak at the Wolfe Research 3rd Annual Materials of the Future conference on June 17, 2026, at 9:15 a.m. Eastern Time. A live webcast of their presentation will be accessible on the company's investor relations website. FMC is a global agricultural sciences company focused on creating innovative crop protection solutions.
FMC stock hits 52-week low at 10.91 USD By Investing.com
FMC Corporation's stock has fallen to a new 52-week low of $10.91, marking a significant 75.12% decrease over the past year, despite analysts predicting profitability this year and InvestingPro suggesting the stock is undervalued. The company faces a substantial debt burden of $4.66 billion. Recent Q1 2026 earnings beat expectations with an adjusted loss per share of $0.23 and revenue of $759 million, leading some analysts like Goldman Sachs and RBC Capital to maintain or raise price targets, while BMO Capital reiterated a Market Perform rating.
